|
|
||||||||
The Journal of Immunology, Vol 157, Issue 3 1176-1183, Copyright © 1996 by American Association of Immunologists
ARTICLES |
JH Tian, LH Miller, DC Kaslow, J Ahlers, MF Good, DW Alling, JA Berzofsky and S Kumar
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
The C-terminal 19-kDa, epidermal growth factor-like region of the merozoite surface protein 1 (MSP1) has been used as a vaccine to induce protective immunity to Plasmodium yoelii in mice and to Plasmodium falciparum in monkeys. To analyze the mechanisms and genetic regulation of this MSP1 vaccine-induced protection, we studied the immunologic correlates of protection in H-2 recombinant and congenic mouse strains on the B10 background. Multiple H-2-linked loci were found to contribute, each with a different mechanism. One locus mapped to the I- A region based on the strong protection in C57BL/10 mice compared with intermediate protection in B10.A(4R) mice and the lack of a difference between B10.AKM and B10.MBR mice. Differences in efficacy of passively transferred antisera from vaccinated C57BL/10 vs B10.A(4R) mice indicated that the protection regulated by the I-A locus was at least in part Ab dependent. Two loci mapped to the right of I-A (FE, H-2S, or H-2D) based on a correlation with the number of H-2k loci to the right of I-A in mice that were I-Ak. One effect was Ab independent and may correspond to a possible negative effect of the I-Ek locus. T cells from protected and nonprotected strains differed in their production of IFN-gamma and TNF-alpha following immunization with MSP1(19), but it was unclear how the differential patterns of cytokine expression related to the level of protection. Thus, MSP1(19) vaccine-induced protection is regulated by H-2-linked loci corresponding to two different immune mechanisms. These findings may indicate the need for more than one Ag in a vaccine to protect an HLA-diverse population.
This article has been cited by other articles:
![]() |
L. Wang, M. W. Goschnick, and R. L. Coppel Oral Immunization with a Combination of Plasmodium yoelii Merozoite Surface Proteins 1 and 4/5 Enhances Protection against Lethal Malaria Challenge Infect. Immun., October 1, 2004; 72(10): 6172 - 6175. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. John, R. A. O'Donnell, P. O. Sumba, A. M. Moormann, T. F. de Koning-Ward, C. L. King, J. W. Kazura, and B. S. Crabb Evidence That Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa J. Immunol., July 1, 2004; 173(1): 666 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Stanisic, L. B. Martin, M. L. Gatton, and M. F. Good Inhibition of 19-kDa C-Terminal Region of Merozoite Surface Protein-1-Specific Antibody Responses in Neonatal Pups by Maternally Derived 19-kDa C-Terminal Region of Merozoite Surface Protein-1-Specific Antibodies but Not Whole Parasite-Specific Antibodies J. Immunol., May 1, 2004; 172(9): 5570 - 5581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, T. R. Jones, M. S. Oakley, H. Zheng, S. P. Kuppusamy, A. Taye, A. M. Krieg, A. W. Stowers, D. C. Kaslow, and S. L. Hoffman CpG Oligodeoxynucleotide and Montanide ISA 51 Adjuvant Combination Enhanced the Protective Efficacy of a Subunit Malaria Vaccine Infect. Immun., February 1, 2004; 72(2): 949 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Stanisic, L. B. Martin, and M. F. Good The Role of the 19-kDa Region of Merozoite Surface Protein 1 and Whole-Parasite-Specific Maternal Antibodies in Directing Neonatal Pups' Responses to Rodent Malaria Infection J. Immunol., November 15, 2003; 171(10): 5461 - 5469. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Stanisic, L. B. Martin, X. Q. Liu, D. Jackson, J. Cooper, and M. F. Good Analysis of Immunological Nonresponsiveness to the 19-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium yoelii: Rescue by Chemical Conjugation to Diphtheria Toxoid (DT) and Enhancement of Immunogenicity by Prior DT Vaccination Infect. Immun., October 1, 2003; 71(10): 5700 - 5713. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wipasa, H. Xu, M. Makobongo, M. Gatton, A. Stowers, and M. F. Good Nature and Specificity of the Required Protective Immune Response That Develops Postchallenge in Mice Vaccinated with the 19-Kilodalton Fragment of Plasmodium yoelii Merozoite Surface Protein 1 Infect. Immun., November 1, 2002; 70(11): 6013 - 6020. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawabata, H. Udono, K. Honma, M. Ueda, H. Mukae, J.-i. Kadota, S. Kohno, and K. Yui Merozoite Surface Protein 1-Specific Immune Response Is Protective against Exoerythrocytic Forms of Plasmodium yoelii Infect. Immun., November 1, 2002; 70(11): 6075 - 6082. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wipasa, C. Hirunpetcharat, Y. Mahakunkijcharoen, H. Xu, S. Elliott, and M. F. Good Identification of T Cell Epitopes on the 33-kDa Fragment of Plasmodium yoelii Merozoite Surface Protein 1 and Their Antibody-Independent Protective Role in Immunity to Blood Stage Malaria J. Immunol., July 15, 2002; 169(2): 944 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Near, A. W. Stowers, D. Jankovic, and D. C. Kaslow Improved Immunogenicity and Efficacy of the Recombinant 19-Kilodalton Merozoite Surface Protein 1 by the Addition of Oligodeoxynucleotide and Aluminum Hydroxide Gel in a Murine Malaria Vaccine Model Infect. Immun., February 1, 2002; 70(2): 692 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ahlborg, I. T. Ling, W. Howard, A. A. Holder, and E. M. Riley Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region Infect. Immun., February 1, 2002; 70(2): 820 - 825. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wipasa, H. Xu, A. Stowers, and M. F. Good Apoptotic Deletion of Th Cells Specific for the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein 1 During Malaria Infection J. Immunol., October 1, 2001; 167(7): 3903 - 3909. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Joshi, A. A. Gam, R. A. Boykins, S. Kumar, J. Sacci, S. L. Hoffman, H. L. Nakhasi, and R. T. Kenney Immunogenicity of Well-Characterized Synthetic Plasmodium falciparum Multiple Antigen Peptide Conjugates Infect. Immun., August 1, 2001; 69(8): 4884 - 4890. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vukovic, P. M. Hogarth, N. Barnes, D. C. Kaslow, and M. F. Good Immunoglobulin G3 Antibodies Specific for the 19-Kilodalton Carboxyl-Terminal Fragment of Plasmodium yoelii Merozoite Surface Protein 1 Transfer Protection to Mice Deficient in Fc-gamma RI Receptors Infect. Immun., May 1, 2000; 68(5): 3019 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ahlborg, I. T. Ling, A. A. Holder, and E. M. Riley Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119 Infect. Immun., April 1, 2000; 68(4): 2102 - 2109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar, W. Collins, A. Egan, A. Yadava, O. Garraud, M. J. Blackman, J. A. G. Patino, C. Diggs, and D. C. Kaslow Immunogenicity and Efficacy in Aotus Monkeys of Four Recombinant Plasmodium falciparum Vaccines in Multiple Adjuvant Formulations Based on the 19-Kilodalton C Terminus of Merozoite Surface Protein 1 Infect. Immun., April 1, 2000; 68(4): 2215 - 2223. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hirunpetcharat, P. Vukovic, X. Q. Liu, D. C. Kaslow, L. H. Miller, and M. F. Good Absolute Requirement for an Active Immune Response Involving B Cells and Th Cells in Immunity to Plasmodium yoelii Passively Acquired with Antibodies to the 19-kDa Carboxyl-Terminal Fragment of Merozoite Surface Protein-1 J. Immunol., June 15, 1999; 162(12): 7309 - 7314. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kang, P. A. Calvo, T. M. Daly, and C. A. Long Comparison of Humoral Immune Responses Elicited by DNA and Protein Vaccines Based on Merozoite Surface Protein-1 from Plasmodium yoelii, a Rodent Malaria Parasite J. Immunol., October 15, 1998; 161(8): 4211 - 4219. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Spencer Valero, S. A. Ogun, S. L. Fleck, I. T. Ling, T. J. Scott-Finnigan, M. J. Blackman, and A. A. Holder Passive Immunization with Antibodies against Three Distinct Epitopes on Plasmodium yoelii Merozoite Surface Protein 1 Suppresses Parasitemia Infect. Immun., August 1, 1998; 66(8): 3925 - 3930. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Becker, R. Wang, R. C. Hedstrom, J. C. Aguiar, T. R. Jones, S. L. Hoffman, and M. J. Gardner Protection of Mice against Plasmodium yoelii Sporozoite Challenge with P. yoelii Merozoite Surface Protein 1 DNA Vaccines Infect. Immun., July 1, 1998; 66(7): 3457 - 3461. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |